Palo Alto Investors LP Long-Term Concentrated

Location: Palo Alto, CA

CIK: 0001306923 · Show all filings

Period: Q2 2015 (← Previous) (Next →)

Filing Date: Aug 14, 2015

Total Value: $2.249B (100.0% shares, 0.0% debt)

Holdings (45)

UTHR UNITED THERAPEUTICS CORP DEL 11.1%
Value $250M Shares 1,439,928 Est. Cost $77.14 Unrealized +133.2%
ANACOR PHARMACEUTICALS INC 10.7%
Value $240M Shares 3,103,027 Est. Cost $23.70 Unrealized
BMRN BIOMARIN PHARMACEUTICAL INC 10.1%
Value $227M Shares 1,660,092 Est. Cost $73.11 Unrealized +69.5%
CLOVIS ONCOLOGY INC 9.4%
Value $211M Shares 2,401,117 Est. Cost $51.97 Unrealized
ABIOMED INC 8.0%
Value $180M Shares 2,742,305 Est. Cost $26.14 Unrealized
AMAG PHARMACEUTICALS INC 6.7%
Value $151M Shares 2,192,141 Est. Cost $28.67 Unrealized
INSM INSMED INC 5.1%
Value $116M Shares 4,733,601 Est. Cost $14.79 Unrealized +53.5%
THORATEC CORP 5.1%
Value $114M Shares 2,560,303 Est. Cost $40.89 Unrealized
KYTHERA BIOPHARMACEUTICALS I 4.3%
Value $97.17M Shares 1,290,292 Est. Cost $40.00 Unrealized
ENDO INTL PLC 3.1%
Value $68.87M Shares 864,604 Est. Cost $89.70 Unrealized
WRIGHT MED GROUP INC 2.4%
Value $54M Shares 2,056,251 Est. Cost $28.27 Unrealized
VNDA VANDA PHARMACEUTICALS INC 2.2%
Value $49.46M Shares 3,897,408 Est. Cost $8.39 Unrealized +28.6%
KARYOPHARM THERAPEUTICS INC 2.1%
Value $47.12M Shares 1,731,530 Est. Cost $29.08 Unrealized
PRTA PROTHENA CORP PLC 1.6%
Value $36.65M Shares 695,918 Est. Cost $22.18 Unrealized +77.9%
GILD GILEAD SCIENCES INC 1.6%
Value $35.06M Shares 299,500 Est. Cost $62.40 Unrealized +21.8%
MOMENTA PHARMACEUTICALS INC 1.5%
Value $33.19M Shares 1,455,176 Est. Cost $14.44 Unrealized
SEQUENOM INC 1.4%
Value $30.47M Shares 10,023,842 Est. Cost $3.91 Unrealized
CELGENE CORP 1.3%
Value $30.35M Shares 262,200 Est. Cost $96.77 Unrealized
FOLD AMICUS THERAPEUTICS INC 1.2%
Value $27.94M Shares 1,974,376 Est. Cost $3.07 Unrealized +291.2%
STAA STAAR SURGICAL CO 1.1%
Value $25.53M Shares 2,642,922 Est. Cost $8.11 Unrealized +14.3%
CYBERONICS INC 1.1%
Value $24.5M Shares 412,000 Est. Cost $52.15 Unrealized
SHIRE PLC 1.1%
Value $23.74M Shares 98,300 Est. Cost $229.35 Unrealized
MEDIVATION INC 0.9%
Value $20.59M Shares 180,300 Est. Cost $86.62 Unrealized
ARIAD PHARMACEUTICALS INC 0.8%
Value $18.46M Shares 2,231,717 Est. Cost $6.82 Unrealized
HEARTWARE INTL INC 0.8%
Value $17.73M Shares 243,868 Est. Cost $87.77 Unrealized
ZELTIQ AESTHETICS INC 0.7%
Value $16.75M Shares 568,436 Est. Cost $26.16 Unrealized
RIGEL PHARMACEUTICALS INC 0.7%
Value $16.62M Shares 5,176,319 Est. Cost $3.43 Unrealized
ISRG INTUITIVE SURGICAL INC 0.7%
Value $15.67M Shares 32,350 Est. Cost $55.94 Unrealized 0.0%
ALIMERA SCIENCES INC 0.6%
Value $13.89M Shares 3,013,793 Est. Cost $4.88 Unrealized
EXAS EXACT SCIENCES CORP 0.5%
Value $11.68M Shares 392,676 Est. Cost $12.83 Unrealized +95.8%
OREXIGEN THERAPEUTICS INC 0.4%
Value $9.56M Shares 1,931,324 Est. Cost $6.46 Unrealized
ACELRX PHARMACEUTICALS INC 0.4%
Value $9.056M Shares 2,135,739 Est. Cost $5.78 Unrealized
IDERA PHARMACEUTICALS INC 0.2%
Value $4.551M Shares 1,226,748 Est. Cost $3.71 Unrealized
XOMA CORP DEL 0.1%
Value $3.1M Shares 799,000 Est. Cost $4.07 Unrealized
HISTOGENICS CORP 0.1%
Value $2.936M Shares 454,545 Est. Cost $11.00 Unrealized
SUNESIS PHARMACEUTICALS INC 0.1%
Value $2.728M Shares 906,263 Est. Cost $2.64 Unrealized
BIOSPECIFICS TECHNOLOGIES CO 0.1%
Value $2.602M Shares 50,436 Est. Cost $34.45 Unrealized
INTREXON CORP 0.1%
Value $2.298M Shares 47,100 Est. Cost $28.82 Unrealized
ALGN ALIGN TECHNOLOGY INC 0.1%
Value $1.741M Shares 27,757 Est. Cost $53.35 Unrealized +10.7%
EPIZYME INC 0.1%
Value $1.47M Shares 61,265 Est. Cost $23.99 Unrealized
ALCOBRA LTD 0.0%
Value $1.024M Shares 156,588 Est. Cost $6.11 Unrealized
DICERNA PHARMACEUTICALS INC 0.0%
Value $986K Shares 70,706 Est. Cost $13.95 Unrealized
CYTK CYTOKINETICS INC 0.0%
Value $831K Shares 123,686 Est. Cost $6.71 Unrealized -2.3%
MALLINCKRODT PUB LTD CO 0.0%
Value $422K Shares 3,588 Est. Cost $90.02 Unrealized
SOPHIRIS BIO INC 0.0%
Value $150K Shares 191,600 Est. Cost $3.88 Unrealized